空心针活检诊断的无非典型增生的良性乳腺乳头状瘤:手术切除与影像随访的结局
回顾性分析399个经影像引导空心针活检诊断的无非典型增生良性乳头状瘤,332个病灶以手术切除或至少24个月影像随访为参考标准,手术升级为恶性肿瘤2.1%、高危病变12.3%;病灶≥15 mm与升级为癌相关,病灶≥15 mm、活检针≥14 G及弹簧加载活检装置与升级为非典型增生相关。
要点
- 无非典型增生良性乳头状瘤手术升级为恶性肿瘤仅2.1%,支持非手术管理。
- 病灶≥15 mm与升级为癌显著相关(p=0.02),也与升级为非典型增生相关(p=0.009)。
- 活检针≥14 G(p=0.027)及使用弹簧加载活检装置(p=0.012)与升级为非典型增生相关。
核心结论
- 经活检证实的无非典型增生良性乳头状瘤手术升级为恶性肿瘤率低(2.1%),支持非手术管理。
- 作者认为可对部分病例(病灶较大及使用较小弹簧加载活检针活检者)行手术。
研究设计与样本
- 回顾性研究,纳入经影像引导经皮空心针活检诊断的无非典型增生良性乳头状瘤399个(329名女性)。
- 参考标准为手术切除或至少24个月影像随访,共332个病灶纳入分析(239个切除,93个随访至少24个月)。
- 统计方法包括卡方检验、Fisher精确检验及Mann-Whitney U检验。
关键影像表现/征象
- 超声是主要活检方式(78.4%,p<0.001)。
- 332个病灶中,7个(2.1%)升级为导管原位癌,41个(12.3%)升级为高危病变。
诊断标准与关键数值
- 高危病变包括非典型导管增生、非典型小叶增生、小叶原位癌、平坦上皮非典型增生及非典型乳头状瘤。
- 病灶大小≥15 mm与升级为非典型增生相关(p=0.009),也与升级为癌相关(p=0.02)。
- 活检针≥14 G与升级为非典型增生相关(p=0.027)。
- 使用弹簧加载活检装置与升级为非典型增生相关(p=0.012)。
临床应用与阅片要点
- 对于影像引导空心针活检诊断的无非典型增生良性乳头状瘤,可考虑非手术管理。
- 病灶≥15 mm或活检采用较小(≥14 G)弹簧加载活检针者,作者认为可选择性行手术切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the surgical upgrade rate to malignancy and high-risk lesions in cases of papilloma without atypia diagnosed with imaging-guided percutaneous core needle biopsy (CNB) and to determine whether any lesion imaging features, biopsy techniques, and pathological factors can predict lesion upgrade to help guide clinical management.
MATERIALS AND METHODS: Benign papillomas without atypia (n = 399) diagnosed with CNB were retrospectively reviewed. The surgical upgrade rate to malignancy or high-risk lesion (atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia and atypical papilloma) was determined. Detection modality (i.e. mammography, ultrasonography (US), magnetic resonance imaging (MRI)), lesion type and size, biopsy-guidance modality (US, stereotactic, MRI), biopsy needle size (<14 G vs ≥14 G), use of vacuum assistance, and presenting symptoms were statistically analyzed. The reference standard for evaluation of upgrade was either excision or at least 24 months of imaging follow-up. Chi Square test and Fisher exact tests were performed for categorical variables, and the Mann-Whitney-U test was used for continuous variables.
RESULTS: Ultrasound was the predominant biopsy modality (78.4 %, p < 0.001). Of the 399 benign papilloma lesions in 329 women, 239 (59.9 %) were excised and 93 others were followed for at least 24 months (total of 332). Of these 332 lesions, 7 (2.1 %) were upgraded to ductal carcinoma in-situ and 41 (12.3 %) to high-risk lesions at excision. Larger lesion size (≥15 mm, p = 0.009), smaller biopsy needle size (≥14 G, p = 0.027), and use of spring-loaded biopsy device (p = 0.012) were significantly associated with upgrade to atypia. Only lesion size (≥15 mm, p = 0.02) was associated with upgrade to cancer.
CONCLUSION: Upgrade to malignancy of biopsy-proven benign papillomas without atypia at the time of surgery was sufficiently low (2.1 %) to support non-operative management. Surgery may be performed for selected cases- those with larger lesion size and those whose biopsies were performed with smaller spring-loaded biopsy needles.
引用
- Polat DS, Knippa EE, Ganti R, et al. Benign breast papillomas without atypia diagnosed with core needle biopsy: Outcome of surgical excision and imaging follow-up. Eur J Radiol. 2020. PMID: 32905954. doi:10.1016/j.ejrad.2020.109237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。